Clopidogrel approved on basis of CAPRIE study.
D001161:Arteriosclerosis / Q000188:drug therapy*; D000077144:Clopidogrel; D017277:Drug Approval; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine